Systems and methods for monitoring medication effectiveness

Inventors

Kohli, Sandeep S. • Widman, David • Kaul, Robert • Ross-Howe, Sara

Assignees

Cloud Dx Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-11612352-B1

Patent

Publication Date

2023-03-28

Expiration Date


Abstract

System for determining real-world effectiveness of various prescribed medications. Here a variety of different types of patient pulse wave measurements (e.g. blood pressure, pulse oximeter, ECG) and other physiological measurements are obtained. This actual data is compared to calculated measurements that would be expected based on the various patient baseline measurements in the absence of medication, schedule of medications, and impact of medications the various patient baseline measurements. If the actual data meets expectations, then the medication is likely acting as anticipated. Depending on which types of data do not meet expectations, problems with one or more previously described medications may be reported. Other types of patient physiological readings, such as temperature, motion, lung function, brain wave function (EEG) and the like may also be obtained, and these additional types of readings can be used to extend the range of different types of drugs/medications that the system can successfully monitor.

Core Innovation

The invention determines a real-world effectiveness of at least one specific medication from a medication regimen comprising a plurality of medications by using patient operable instrumentation that obtains actual patient pulse wave measurements of different types. The measurements include electrode-based time varying electrocardiograph (ECG) readings, time varying blood oxygen saturation levels, and time varying blood pressure measurements, and the system is unitized with a common processor and memory controlled together with the physiological monitoring devices.

For the same patient, the method obtains a plurality of individual medication impact parameters that provide information on how an individual known specific medication alters a specific type of pulse wave measurements, and obtains a plurality of patient reference information that provides baseline pulse wave measurement information in an absence of patient medication. Using the patient medication schedule information and a known time, the processor calculates expected patient pulse wave measurements based on the patient reference information and the medication impact parameters.

The processor analyzes actual patient pulse wave measurements obtained at the known time and determines which types are inconsistent with the expected measurements, thus producing specific medications with inconsistent findings. The method stores the specific medications with inconsistent findings, and determines effectiveness based on the inconsistent findings, where the effectiveness comprises an impact of the specific medication on actual pulse wave measurements as compared to calculated expected pulse wave measurements for the medication regimen.

The described approach is extended by refining the effectiveness evaluation through comparing actual and calculated expected pulse wave measurements for the medication regimen, and by deriving additional reporting context such as alarm information based on blood oxygen saturation, blood pressure measurements, or electrocardiograph readings outside established boundaries. In addition, the workflow supports operational implementation with a common processor system and includes the ability to obtain synchronized pulse wave-related information tied to the same patient heart beats, including hemoglobin absorbance-related information.

Claims Coverage

The document contains one independent method claim (clm-00001). The claim covers determining real-world medication effectiveness by comparing multi-type actual pulse wave measurements against processor-calculated expected pulse wave measurements derived from patient medication schedule information, patient baseline reference information, and medication impact parameters, and then identifying medications producing inconsistent findings.

Unitized common-processor physiological monitoring for multi-type pulse-wave measurements

Obtaining patient operable instrumentation comprising a plurality of physiological monitoring devices configured to obtain electrode-based time varying electrocardiograph (ECG) readings, time varying blood oxygen saturation levels, and time varying blood pressure measurements, where the instrumentation and physiological monitoring devices are a unitized, common processor controlled, system.

Medication impact parameters and patient baseline reference information

Obtaining a plurality of individual medication impact parameters, each providing information on how an individual known specific medication alters a specific type of pulse wave measurements; obtaining a plurality of patient reference information, each providing information on a specific type of patient baseline pulse wave measurement in an absence of patient medication.

Expected pulse wave calculation from schedule, known time, reference, and impact parameters

Obtaining patient medication schedule information regarding the plurality of medications and medication dosing schedules for the patient and storing the medication schedule in memory; obtaining and analyzing actual pulse wave measurements at a known time; calculating expected patient pulse wave measurements based on the medication schedule information, the known time, the patient reference information, and the medication impact parameters.

Inconsistent findings identification and effectiveness determination

Determining which types of actual pulse wave measurements are inconsistent with the expected pulse wave measurements, thus producing specific medications with inconsistent findings; storing at least the specific medications with inconsistent findings; determining effectiveness based on the inconsistent findings, where effectiveness comprises an impact of the at least one specific medication on actual patient pulse wave measurements as compared to calculated expected patient pulse wave measurements for the medication regimen.

Overall, the independent claim ties medication effectiveness to an expected-versus-actual comparison across multiple types of pulse wave measurements, using medication impact parameters and patient baseline reference information aligned with the patient medication schedule at a known time, and then evaluating effectiveness from the inconsistent findings.

Stated Advantages

Produces specific medications with inconsistent findings by identifying pulse-wave measurement types inconsistent with expected patient pulse-wave measurements.

Determines effectiveness comprising the impact of a specific medication on actual patient pulse-wave measurements compared to calculated expected patient pulse-wave measurements for the medication regimen.

Enables alarm-related risk reporting when blood oxygen saturation, blood pressure measurements, or electrocardiograph readings are outside established boundaries together with inconsistent findings, indicating risk of being ineffectively treated by specific medications.

Documented Applications

Assessing real-world effectiveness of at least one specific medication within a medication regimen comprising a plurality of medications for a patient, based on multi-type pulse wave measurements compared to expected measurements.

Reporting patient risk of being ineffectively treated by specific medications using alarm information derived from blood oxygen saturation, blood pressure measurements, or electrocardiograph readings outside established boundaries when inconsistent findings are obtained.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.